Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    CAS 707-36-8 manufacturers and suppliers on PharmaCompass

    Client Email Product

    CAS 707-36-8

    Manufacturers/Suppliers

    MARKET PLACE

    PharmaCompass
    CAS 707-36-8
    Also known as: 707-36-8, 5-chloro-1,3-dimethyladamantane, 1,3-dimethyl-5-chloroadamantane, 1-chloro-3,5-dimethyl-adamantane, Q8e5db8wpy, Mfcd00074841
    Molecular Formula
    C12H19Cl
    Molecular Weight
    198.73  g/mol
    InChI Key
    PXDRFQZLDWZHPX-UHFFFAOYSA-N
    FDA UNII
    Q8E5DB8WPY
    1 2D Structure

    CAS 707-36-8

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    1-chloro-3,5-dimethyladamantane
    2.1.2 InChI
    InChI=1S/C12H19Cl/c1-10-3-9-4-11(2,6-10)8-12(13,5-9)7-10/h9H,3-8H2,1-2H3
    2.1.3 InChI Key
    PXDRFQZLDWZHPX-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC12CC3CC(C1)(CC(C3)(C2)Cl)C
    2.2 Other Identifiers
    2.2.1 UNII
    Q8E5DB8WPY
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. 707-36-8

    2. 5-chloro-1,3-dimethyladamantane

    3. 1,3-dimethyl-5-chloroadamantane

    4. 1-chloro-3,5-dimethyl-adamantane

    5. Q8e5db8wpy

    6. Mfcd00074841

    7. Tricyclo[3.3.1.13,7]decane, 1-chloro-3,5-dimethyl-

    8. Chlorodimethyladamantane

    9. Unii-q8e5db8wpy

    10. Ec 615-149-2

    11. Schembl810646

    12. 1-chloro-3,5-dimethyltricyclo[3.3.1.13,7]decane

    13. 3,5-dimethyl-1-chloroadamantane

    14. Dtxsid70390748

    15. 5-chloro-1,3-dimethyl Adamantane

    16. 1-chloranyl-3,5-dimethyl-adamantane

    17. Stl452977

    18. Akos015850596

    19. Cs-w010523

    20. As-60554

    21. Sy053163

    22. Db-019122

    23. Adamantane, 1-chloro-3,5-dimethyl-

    24. C1981

    25. Ft-0620206

    26. Memantine Related Compound C [usp-rs]

    27. D78261

    28. A836976

    29. Memantine Related Compound C [usp Impurity]

    30. 1-chloro-3,5-dimethyltricyclo[3.3.1.1~3,7~]decane

    31. Tricyclo(3.3.1.1(sup 3,7))decane, 1-chloro-3,5-dimethyl-

    2.4 Create Date
    2005-09-06
    3 Chemical and Physical Properties
    Molecular Weight 198.73 g/mol
    Molecular Formula C12H19Cl
    XLogP34.8
    Hydrogen Bond Donor Count0
    Hydrogen Bond Acceptor Count0
    Rotatable Bond Count0
    Exact Mass198.1175283 g/mol
    Monoisotopic Mass198.1175283 g/mol
    Topological Polar Surface Area0 Ų
    Heavy Atom Count13
    Formal Charge0
    Complexity240
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count2
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    ListList of Suppliers
    Full View ScreenFull Screen View
    refresh Reset Filter
    refresh Reset Filter
    price-trend Ask Us

    Cangzhou Senary Chemical Science-te...

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      1-Bromo-3,5-dimethyladamantane

      PDF Supplier PDF
      URL Supplier Web Content
      941-37-7
      Memantine Hydrochloride
      Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
      Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Cangzhou Senary Chemical Science-te...

      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag China
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        1,3-dimethyl adamantane

        PDF Supplier PDF
        URL Supplier Web Content
        702-79-4
        Memantine Hydrochloride
        Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
        Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content
        Ask Us for Pharmaceutical Supplier and Partner
        Ask Us, Find A Supplier / Partner
        No Commissions, No Strings Attached, Get Connected for FREE

        What are you looking for?

        How can we help you?

        The request can't be empty

        Please read our Privacy Policy carefully

        You must agree to the privacy policy

        The name can't be empty
        The company can't be empty.
        The email can't be empty Please enter a valid email.
        The mobile can't be empty
        fermion-oy-2024-05-13

        Access Virtual Booth

        Contact Supplier

        View Presentation

        Inke S.A: APIs manufacturing plant.

        Access Virtual Booth

        Contact Supplier

        View Presentation

        Post Enquiry
        POST ENQUIRY

        Market Place

        Market Place

        PharmaCompass

        Home

        Market Place

        Menu

        Post Enquiry

        Post Enquiry

        Market Place

        Market Place

        Search